Showing 1 - 20 results of 24 for search 'Ross A.D. Bathgate', query time: 0.05s
Refine Results
-
1
-
2
-
3
C-terminus of the B-chain of relaxin-3 is important for receptor activity. by Fazel Shabanpoor, Ross A D Bathgate, John D Wade, Mohammed Akhter Hossain
Published 2013-01-01
Article -
4
In a Class of their own – RXFP1 and RXFP2 are unique members of the LGR family by Emma June Petrie, Emma June Petrie, Samantha eLagaida, Samantha eLagaida, Ashish eSethi, Ashish eSethi, Ross A.D. Bathgate, Ross A.D. Bathgate, Paul Raymond Gooley, Paul Raymond Gooley
Published 2015-09-01
Article -
5
A Real-Time, Plate-Based BRET Assay for Detection of cGMP in Primary Cells by Adam L. Valkovic, Martina Kocan, Brad Hoare, Sarah Marshall, Daniel J. Scott, Ross A. D. Bathgate
Published 2022-02-01
Article -
6
-
7
-
8
Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS. by Bryna Suet Man Chow, Elaine Guo Yan Chew, Chongxin Zhao, Ross A D Bathgate, Tim D Hewitson, Chrishan S Samuel
Published 2012-01-01
Article -
9
-
10
-
11
-
12
-
13
-
14
Diazepam is not a direct allosteric modulator of α1‐adrenoceptors, but modulates receptor signaling by inhibiting phosphodiesterase‐4 by Lisa M. Williams, Xiaoji He, Tasneem M. Vaid, Alaa Abdul‐Ridha, Alice R. Whitehead, Paul R. Gooley, Ross A.D. Bathgate, Spencer J. Williams, Daniel J. Scott
Published 2019-02-01
Article -
15
Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin by Shoni Bruell, Ashish Sethi, Nicholas Smith, Daniel J. Scott, Mohammed Akhter Hossain, Qing-Ping Wu, Zhan-Yun Guo, Emma J. Petrie, Paul R. Gooley, Ross A. D. Bathgate
Published 2017-06-01
Article -
16
Gram scale preparation of clozapine N-oxide (CNO), a synthetic small molecule actuator for muscarinic acetylcholine DREADDs by Phillip L. van der Peet, Christian Gunawan, Alaa Abdul-Ridha, Sherie Ma, Daniel J. Scott, Andrew L. Gundlach, Ross A.D. Bathgate, Jonathan M. White, Spencer J. Williams
Published 2018-01-01
Article -
17
Ligands selectively tune the local and global motions of neurotensin receptor 1 (NTS1) by Fabian Bumbak, Miquel Pons, Asuka Inoue, Juan Carlos Paniagua, Fei Yan, Hongwei Wu, Scott A. Robson, Ross A.D. Bathgate, Daniel J. Scott, Paul R. Gooley, Joshua J. Ziarek
Published 2023-01-01
Article -
18
Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design by Annunziata D'Ercole, Annunziata D'Ercole, Silvia Nistri, Lorenzo Pacini, Lorenzo Pacini, Alfonso Carotenuto, Federica Santoro, Anna Maria Papini, Anna Maria Papini, Ross A. D. Bathgate, Daniele Bani, Paolo Rovero, Paolo Rovero
Published 2022-08-01
Article -
19
Relaxin-2 Does Not Ameliorate Nephropathy in an Experimental Model of Type-1 Diabetes by Thomas Bernd Dschietzig, Katharina Krause-Relle, Maud Hennequin, Karoline von Websky, Jan Rahnenführer, Jana Ruppert, Hans Jürgen Grön, Franz Paul Armbruster, Ross A. D. Bathgate, Joerg R. Aschenbach, Wolf-Georg Forssmann, Berthold Hocher
Published 2015-03-01
Article -
20
The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experime... by Fariha Alam, Tracey A. Gaspari, Barbara K. Kemp-Harper, Edward Low, Aaron Aw, Dorota Ferens, Iresha Spizzo, Ann-Maree Jefferis, Praveen Praveen, Robert E. Widdop, Ross A.D. Bathgate, Mohammed Akhter Hossain, Chrishan S. Samuel
Published 2023-04-01
Article